Alex N. Eberlé

5.8k total citations
161 papers, 4.8k citations indexed

About

Alex N. Eberlé is a scholar working on Molecular Biology, Cell Biology and Endocrine and Autonomic Systems. According to data from OpenAlex, Alex N. Eberlé has authored 161 papers receiving a total of 4.8k indexed citations (citations by other indexed papers that have themselves been cited), including 79 papers in Molecular Biology, 41 papers in Cell Biology and 40 papers in Endocrine and Autonomic Systems. Recurrent topics in Alex N. Eberlé's work include Regulation of Appetite and Obesity (39 papers), Biochemical Analysis and Sensing Techniques (39 papers) and melanin and skin pigmentation (38 papers). Alex N. Eberlé is often cited by papers focused on Regulation of Appetite and Obesity (39 papers), Biochemical Analysis and Sensing Techniques (39 papers) and melanin and skin pigmentation (38 papers). Alex N. Eberlé collaborates with scholars based in Switzerland, United Kingdom and United States. Alex N. Eberlé's co-authors include Sylvie Froidevaux, Walter Siegrist, R. Schwyzer, John E. Walker, J. Girard, A. Heppeler, Helmut R. Maëcke, Rolf Geiger, Theodor Wieland and Flavio Solca and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

In The Last Decade

Alex N. Eberlé

160 papers receiving 4.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alex N. Eberlé Switzerland 38 2.1k 1.1k 1.1k 925 894 161 4.8k
Maria A. Bednarek United States 31 2.3k 1.1× 465 0.4× 1.2k 1.2× 1.6k 1.7× 333 0.4× 64 5.1k
Cédric Govaerts Belgium 34 2.9k 1.4× 345 0.3× 702 0.7× 456 0.5× 340 0.4× 58 4.8k
Rubén J. Boado United States 55 4.8k 2.3× 1.1k 1.0× 385 0.4× 246 0.3× 725 0.8× 197 9.3k
Waleed Danho United States 33 2.0k 0.9× 497 0.5× 355 0.3× 176 0.2× 256 0.3× 99 3.5k
Emanuel Escher Canada 39 3.0k 1.4× 483 0.4× 202 0.2× 357 0.4× 186 0.2× 192 4.7k
Eric Trinquet France 36 2.8k 1.3× 484 0.4× 414 0.4× 620 0.7× 202 0.2× 67 4.1k
Henry T. Keutmann United States 51 4.3k 2.0× 523 0.5× 211 0.2× 132 0.1× 677 0.8× 128 6.7k
Howard S. Tager United States 43 3.1k 1.5× 293 0.3× 135 0.1× 221 0.2× 436 0.5× 110 5.7k
Brett M. Paterson Australia 41 2.1k 1.0× 812 0.7× 368 0.3× 74 0.1× 327 0.4× 88 4.6k
Richard G.H. Cotton Australia 42 3.9k 1.8× 315 0.3× 213 0.2× 190 0.2× 468 0.5× 260 7.3k

Countries citing papers authored by Alex N. Eberlé

Since Specialization
Citations

This map shows the geographic impact of Alex N. Eberlé's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alex N. Eberlé with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alex N. Eberlé more than expected).

Fields of papers citing papers by Alex N. Eberlé

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alex N. Eberlé. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alex N. Eberlé. The network helps show where Alex N. Eberlé may publish in the future.

Co-authorship network of co-authors of Alex N. Eberlé

This figure shows the co-authorship network connecting the top 25 collaborators of Alex N. Eberlé. A scholar is included among the top collaborators of Alex N. Eberlé based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alex N. Eberlé. Alex N. Eberlé is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bigliardi, Paul, Bhimsen Rout, Aakanksha Pant, et al.. (2017). Specific Targeting of Melanotic Cells with Peptide Ligated Photosensitizers for Photodynamic Therapy. Scientific Reports. 7(1). 15750–15750. 15 indexed citations
2.
Lindinger, Peter W., Martine Christe, Alex N. Eberlé, et al.. (2015). Important mitochondrial proteins in human omental adipose tissue show reduced expression in obesity. Data in Brief. 4. 40–43. 5 indexed citations
3.
Ricklin, Daniel, et al.. (2009). Oligohis‐tags: mechanisms of binding to Ni2+‐NTA surfaces. Journal of Molecular Recognition. 22(4). 270–279. 176 indexed citations
4.
Froidevaux, Sylvie & Alex N. Eberlé. (2002). HOMOLOGOUS REGULATION OF MELANOCORTIN-1 RECEPTOR (MC1R) EXPRESSION IN MELANOMA TUMOR CELLS IN VIVO. Journal of Receptors and Signal Transduction. 22(1-4). 111–121. 13 indexed citations
5.
Froidevaux, Sylvie, Alex N. Eberlé, Martine Christe, et al.. (2002). Neuroendocrine tumor targeting: Study of novel gallium‐labeled somatostatin radiopeptides in a rat pancreatic tumor model. International Journal of Cancer. 98(6). 930–937. 80 indexed citations
6.
Bigliardi‐Qi, Mei, et al.. (2000). β-Endorphin Stimulates Cytokeratin 16 Expression and Downregulates μ-Opiate Receptor Expression in Human Epidermis. Journal of Investigative Dermatology. 114(3). 527–532. 52 indexed citations
7.
Chluba, Johanna, et al.. (1997). Cloning of a human multispanning membrane protein cDNA: evidence for a new protein family. Gene. 197(1-2). 195–204. 33 indexed citations
8.
Bagutti, Claudia, Barbara Stolz, Rainer Albert, et al.. (1994). [111In]-DTPA-labeled analogues of α-melanocyte-stimulating hormone for melanoma targeting: Receptor bindingin vitro andin vivo. International Journal of Cancer. 58(5). 749–755. 48 indexed citations
10.
Baker, Bridget I., et al.. (1993). Synthesis and Biological Activity of Highly Tritiated Rat/Human Melanin‐Concentrating Hormone. Annals of the New York Academy of Sciences. 680(1). 489–492. 3 indexed citations
11.
Eberlé, Alex N., et al.. (1993). D1 Dopamine Receptor mRNA in B16 Mouse Melanoma Cellsa. Annals of the New York Academy of Sciences. 680(1). 660–662. 4 indexed citations
12.
Baumann, J. B., et al.. (1993). Receptor Binding and Biological Activity of IL-α, IL-1β, IL-1β Analogues and an IL-1 Antagonist in A375 Human Melanoma Cells. Journal of Receptor Research. 13(1-4). 245–262. 5 indexed citations
13.
Eberlé, Alex N. & Martin Huber. (1991). Antisense Peptides: Tools for Receptor Isolation? Lack of Antisense Msh and Acth to Interact with their Sense Peptides and to Induce Receptor-Specific Antibodies. Journal of Receptor Research. 11(1-4). 13–43. 11 indexed citations
15.
Eberlé, Alex N., et al.. (1988). Human growth hormone in urine: development of an ultrasensitive radiometric assay. Cellular and Molecular Life Sciences. 44(2). 155–157. 7 indexed citations
16.
Girard, J., et al.. (1987). Growth Hormone in Urine: Development of an Ultrasensitive Assay Applicable to Plasma and Urine. Hormone Research. 28(1). 71–80. 42 indexed citations
17.
Scimonelli, Teresa, et al.. (1987). Changes in Alpha-Melanocyte-Stimulating Hormone Content in Discrete Hypothalamic Areas of the Male Rat during a Twenty-Four-Hour Period. Hormone Research. 27(2). 78–83. 7 indexed citations
18.
Landolt, A. M., Anton Valavanis, J. Girard, & Alex N. Eberlé. (1986). CORTICOTROPHIN‐RELEASING FACTOR‐TEST USED WITH BILATERAL, SIMULTANEOUS INFERIOR PETROSAL SINUS BLOOD‐SAMPLING FOR THE DIAGONOSIS OF PITUITARY‐DEPENDENT CUSHING'S DISEASE. Clinical Endocrinology. 25(6). 687–696. 71 indexed citations
19.
Eberlé, Alex N.. (1981). Structure and Chemistry of the Peptide Hormones of the Intermediate Lobe. Novartis Foundation symposium. 81. 13–31. 14 indexed citations
20.
Eberlé, Alex N., Rolf Geiger, & Theodor Wieland. (1981). Perspectives in peptide chemistry. KARGER eBooks. 154 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026